Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy
Public ClinicalTrials.gov record NCT00151983. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Prospective, Open-Label, Multi-Center Study Evaluating the Safety and Tolerability of Methylphenidate Transdermal System (MTS) in Children Aged 6-12 Previously Treated With Extended-Release Methylphenidate Product.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will assess the safety and tolerability of MTS while attempting to establish the appropriate starting dose for subjects previously on an existing long-acting methylphenidate product.
Study identification
- NCT ID
- NCT00151983
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 175 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 6 Years to 12 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 2005 (Type not available)
- Primary completion
- Jul 2006 (Actual)
- Completion
- Jul 2006 (Actual)
- Last update posted
- Jul 9, 2015
2005 – 2006
United States locations
- U.S. sites
- 18
- U.S. states
- 15
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Meadowbrook Research, Inc. | Scottsdale | Arizona | — | — |
| Psychiatric Centers at San Diego | San Marcos | California | — | — |
| Alpine Clinical Research Center | Boulder | Colorado | — | — |
| Miami Research Associates, Inc. | Miami | Florida | — | — |
| Capstone Clinical Research | Libertyville | Illinois | — | — |
| Pedia Research, LLC | Owensboro | Kentucky | — | — |
| ProMed Pediatrics | Kalamazoo | Michigan | — | — |
| Children's Specialized Hospital | Toms River | New Jersey | — | — |
| North Carolina Neuropsychiatry PA | Chapel Hill | North Carolina | — | — |
| Ohio State University | Columbus | Ohio | — | — |
| IPS Research Company | Oklahoma City | Oklahoma | — | — |
| Oregon Center for Clinical Investigations (OCCI, Inc.) | Portland | Oregon | — | — |
| CNS Research Institute | Philadelphia | Pennsylvania | — | — |
| Western Psychiatric Institute & Clinic | Pittsburgh | Pennsylvania | — | — |
| Claghorn-Lesem Research Clinic | Bellaire | Texas | — | — |
| ADHD Clinic of San Antonio | San Antonio | Texas | — | — |
| NeuroScience, Inc. | Herndon | Virginia | — | — |
| Monarch Medical Research | Norfolk | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00151983, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 9, 2015 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00151983 live on ClinicalTrials.gov.